A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules

NCT03340961 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Rosacea

Interventions

DRUG: DFD-29 Extended Release Capsules (40 mg)
DRUG: DFD-29 Extended Release Capsules (20 mg)
DRUG: Oraycea® (doxycycline) Capsules
DRUG: Placebo Capsules

Sponsor

Dr. Reddy's Laboratories Limited